NAS:HKPD (Hong Kong)
Â
Class A
$
0.44
-0.019 (-4.33%)
10:08 PM EST
Business Description
Cellyan Biotechnology Co Ltd
ISIN : KYG6365B1041
Share Class Description:
HKPD: Class ATotal Employee Number:
27Compare
Compare
Traded in other countries / regions
HKPD.USA IPO Date
2025-01-15Description
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.09 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.44 | |||||
Debt-to-EBITDA | 5.27 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.6 | |||||
Beneish M-Score | -1.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.32 | |||||
9-Day RSI | 54.25 | |||||
14-Day RSI | 50.08 | |||||
3-1 Month Momentum % | -34.13 | |||||
6-1 Month Momentum % | -46.59 | |||||
12-1 Month Momentum % | -69.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.93 | |||||
Quick Ratio | 2.73 | |||||
Cash Ratio | 0.82 | |||||
Days Inventory | 13.94 | |||||
Days Sales Outstanding | 108.79 | |||||
Days Payable | 37.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -39.3 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.81 | |||||
Operating Margin % | -3.75 | |||||
Net Margin % | -4.29 | |||||
EBITDA Margin % | 2.63 | |||||
FCF Margin % | -3.17 | |||||
OCF Margin % | -2.62 | |||||
ROE % | -13.6 | |||||
ROA % | -7.21 | |||||
ROIC % | -9.66 | |||||
ROC (Joel Greenblatt) % | -12.15 | |||||
ROCE % | -10.05 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.29 | |||||
PB Ratio | 0.92 | |||||
Price-to-Tangible-Book | 0.96 | |||||
EV-to-EBIT | -15.03 | |||||
EV-to-EBITDA | 22.99 | |||||
EV-to-Revenue | 0.61 | |||||
EV-to-FCF | -19.09 | |||||
| Price-to-Net-Current-Asset-Value | 1.11 | |||||
Earnings Yield (Greenblatt) % | -6.65 | |||||
FCF Yield % | -5.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HKPD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellyan Biotechnology Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 16.36 | ||
| EPS (TTM) ($) | -0.064 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 64.78 | ||
| 14-Day RSI | 50.08 | ||
| 14-Day ATR ($) | 0.053305 | ||
| 20-Day SMA ($) | 0.41069 | ||
| 12-1 Month Momentum % | -69.45 | ||
| 52-Week Range ($) | 0.3176 - 2.58 | ||
| Shares Outstanding (Mil) | 23.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cellyan Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cellyan Biotechnology Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-11-30 | In 139 days | ||
| First quarter earnings results for 2027 | 2026-08-31 | In 48 days | ||
| Annual report for 2026 | 2026-08-14 | In 31 days | ||
| General meeting for 2026 | 2026-07-31 | In 17 days | ||
| Fourth quarter earnings results for 2026 | 2026-07-10 | 0.45 (-0.07%) | ||
| Annual report for 2025 | 2025-08-14 | 1.10 (+1.85%) |
Show
Entries
Cellyan Biotechnology Co Ltd Frequently Asked Questions
What is Cellyan Biotechnology Co Ltd(HKPD)'s stock price today?
The current price of HKPD is $0.44. The 52 week high of HKPD is $2.58 and 52 week low is $0.32.
When is next earnings date of Cellyan Biotechnology Co Ltd(HKPD)?
The next earnings date of Cellyan Biotechnology Co Ltd(HKPD) is 2026-08-31 Est..
Does Cellyan Biotechnology Co Ltd(HKPD) pay dividends? If so, how much?
Cellyan Biotechnology Co Ltd(HKPD) does not pay dividend.
Guru Commentaries on NAS:HKPD
No articles.
Press Release
Articles on Cellyan Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers